Although further exploration is still needed, our results indicate that the activation of CAMK4/NUR77 axis may contribute to the improvement of insulin sensitivity in trophoblast cells, which provides a potential target for GDM treatment. This evidence concerns the gene NR4A1 and gestational diabetes.